Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnosing left ventricular dysfunction after myocardial infarction: the Dundee algorithm

D Darbar1, N Gillespie, A M Choy

  • 1Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, USA.

QJM : Monthly Journal of the Association of Physicians
|February 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial.

Acta cardiologica·2023
Same author

Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21.

Trials·2022
Same author

Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.

Journal of medical case reports·2022
Same author

Tumour biomarkers: association with heart failure outcomes.

Journal of internal medicine·2020
Same author

Novel endotypes in heart failure: effects on guideline-directed medical therapy.

European heart journal·2018
Same author

Sacubitril and valsartan fixed combination to reduce heart failure events in post-acute myocardial infarction patients.

Drugs of today (Barcelona, Spain : 1998)·2017
Same journal

Familial pulmonary fibrosis due to pathogenic TERT variant presenting with a UIP-PPFE phenotype.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Corkscrew Oesophagus Due to Distal Oesophageal Spasm.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Correction to: Integrated care management for patients following acute stroke: a systematic review.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Methodological concerns regarding blinding and long term efficacy of fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Media framing of GLP-1/GIP therapies in Japan: Lessons for aging universal health coverage systems.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Regional heterogeneity in psoriasis area and severity index response to fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026
See all related articles

A new bedside algorithm can identify patients with left ventricular dysfunction after acute myocardial infarction (AMI). This helps determine who benefits most from angiotensin converting enzyme (ACE) inhibitors.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Diagnostics

Background:

  • Angiotensin converting enzyme (ACE) inhibitors show greatest benefit in patients with left ventricular (LV) dysfunction post-acute myocardial infarction (AMI).
  • Early LV function assessment after AMI is challenging due to resource and personnel limitations.
  • A bedside clinical algorithm is needed to identify patients with LV dysfunction (LVEF ≤ 40%) as an alternative to echocardiography.

Purpose of the Study:

  • To devise and validate a clinical algorithm for bedside use to identify patients with left ventricular ejection fraction (LVEF) ≤ 40% after AMI.
  • To provide a tool for identifying patients who would benefit from ACE inhibitor therapy.

Main Methods:

  • A clinical algorithm was developed based on specific criteria: clinical signs of heart failure, anterior myocardial infarction with Q-wave, or lack of thrombolytic therapy in specific high-risk patients.

Related Experiment Videos

  • The algorithm was prospectively tested in two hospital coronary care units (UK and USA).

    • Main Results:

    • In the UK center, the algorithm demonstrated 82% sensitivity and 72% specificity for identifying patients with LVEF ≤ 40%.
    • In the US center, sensitivity was 91% and specificity was 78% for identifying LV dysfunction.
    • The algorithm proved effective in both centers for identifying patients with reduced LVEF.

    Conclusions:

    • A simple clinical algorithm has been validated for bedside use.
    • This algorithm reliably identifies patients who would benefit from ACE inhibitors following AMI.
    • It serves as a valuable alternative to echocardiography for early risk stratification.